ReviewIn vivo (Athens, Greece)
Textbook Outcome After Esophagectomy for Esophageal Cancer: Current Evidence and Future Perspectives.
Review in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Esophagectomy is an essential treatment for resectable esophageal cancer. However, perioperative morbidity and mortality are higher and postoperative hospital stay is longer than other gastrointestinal malignancies. However, quality of perioperative surgical course affects both short- and long-term oncological outcomes in various malignancies. Recently, textbook outcome (TO)/textbook oncological outcome (TOO) are developed to evaluate quality of perioperative surgical course. TO/TOO included various perioperative elements and introduced in various malignancies. In esophageal cancer surgery, in 2017, TO for esophageal cancer (EC) defined and included 10 short-term surgical outcomes (curative resection, no intraoperative complications, R0 resection, number of harvest lymph node, no sever postoperative complication, no reintervention, no readmission intensive care unit, no readmission, no prolonged hospital stay, and no mortality). In 2021, TO for EC redefinition was made and included nine revised short-term surgical parameters. Previous studies demonstrated that achieved TO associated with better survival after esophagectomy for EC. To optimize esophagectomy for EC, it is necessary to understand the characteristics of each study before the widespread implementation of TO in clinical practice. This review summarizes the background, current status, and future perspectives of TO for resectable EC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.